Search hospitals > South Carolina > Greenville
Greenville Cancer Treatment Center
Claim this profileGreenville, South Carolina 29605
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Lymphoma
163 reported clinical trials
4 medical researchers
Summary
Greenville Cancer Treatment Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma and other specialties. Greenville Cancer Treatment Center is involved with conducting 163 clinical trials across 303 conditions. There are 4 research doctors associated with this hospital, such as Ki Chung, MD, Tarek M. Sabagh, Jhansi L. Koduri, and W. Jeff Edenfield, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Leukemia
Global LeaderStage II
Stage I
CD7 positive
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside5 years of reported clinical research
Expert in Cancer
Expert in Tumors
90 reported clinical trials
188 drugs studied
Tarek M. SabaghMiami Valley Hospital South4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
60 reported clinical trials
112 drugs studied
Jhansi L. KoduriMiami Valley Hospital South1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
19 drugs studied
W. Jeff Edenfield, MDGreenville Health System Cancer Institute1 year of reported clinical research
Studies Cancer
Studies Endometrial Cancer
4 reported clinical trials
5 drugs studied
Clinical Trials running at Greenville Cancer Treatment Center
Breast Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Melanoma
Colon Cancer
Colorectal Cancer
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Greenville Cancer Treatment Center?
Greenville Cancer Treatment Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Cancer, Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Lymphoma and other specialties. Greenville Cancer Treatment Center is involved with conducting 163 clinical trials across 303 conditions. There are 4 research doctors associated with this hospital, such as Ki Chung, MD, Tarek M. Sabagh, Jhansi L. Koduri, and W. Jeff Edenfield, MD.